US health authorities call for a pause in the use of the Johnson & Johnson coronavirus vaccine after reports of blood clotting

America, Coronavirus, Health, Janssen, Science, Side Effects, USA, Vaccine

The Food and Drug Administration (FDA) said six cases in 6.8 million doses had been reported and it was acting “out of an abundance of caution”. Johnson & Johnson said it was also delaying vaccine rollout in Europe. The US move follows similar rare cases in the AstraZeneca vaccine, which has prompted some curbs in its use. report



** This post was originally published on April 13, 2021 **